The News
Cerebras Systems filed an amended S-1 on May 4 to sell 28 million Class A shares at $115–125 per share, a $3.5 billion raise at a valuation up to $26.6 billion. The company will list on Nasdaq under CBRS.
The price range implies roughly a 15% step-up from Cerebras's $23 billion private valuation in February, a modest move over three months. Banks are fielding approximately $10 billion in indicated orders for the $3.5 billion on offer. At nearly 3× oversubscribed, this thing is going to price above the range.
The View
The revenue base is real and concentrated. Cerebras posted $510 million of 2025 revenue, up from $290 million in 2024, a 76% YoY clip on a non-trivial base. The company also disclosed $24.6 billion in remaining performance obligations, the contracted-but-unrecognized backlog. That's an enormous number for a company this size, and the bulk of it is reportedly tied to OpenAI and a small handful of UAE-affiliated entities. Concentration runs both ways, validating the technology while exposing the financials to any single counterparty's roadmap, and that exposure is the first thing IPO buyers are underwriting.
Cerebras sells wafer-scale silicon. Its product is the WSE (wafer-scale engine), which bundles silicon at the entire-wafer level where GPU makers dice wafers into discrete chips. The architecture is genuinely differentiated; that's the entire pitch. It also means the company competes on workload fit, away from Nvidia's price/performance curves. They're betting the workloads matter more than the unit economics. For training runs at frontier scale, where memory bandwidth dominates, that bet has been working.
The market is hungry for AI infrastructure exposure outside Nvidia. NVDA is a four-trillion-dollar-plus name. Funds that can't add concentrated GPU exposure can buy CBRS. That accounts for a meaningful chunk of the order-book demand, and a good share of it is positioning with no particular fundamental conviction behind it.
Room for Disagreement
The bear case is the customer concentration, full stop. If OpenAI shifts its training mix toward in-house silicon (which it's been telegraphing) or toward Nvidia's next generation at scale, the $24.6B in backlog becomes a number with footnotes. Cerebras has been transparent about the concentration in its filings, and the market may still be pricing the optimistic scenario.
Notable
- The February 2026 private round at $23B was led by Tiger Global and others
- $10B indicated demand against $3.5B on offer suggests pricing well above the $115–125 range; final pricing should land closer to $140
- 2024 revenue was about $290M, so 2025's $510M is a 76% YoY clip
Bottom Line
If you're allocating to AI infrastructure as a public-equity sleeve, CBRS is going to be hard to ignore on day one. If you're a builder evaluating Cerebras hardware, the IPO leaves the technical story unchanged and makes their pricing power and capacity commitments more rigid. Lock in your terms before the post-IPO hangover.